Anlai Wang
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Platelet Disorders and Treatments
- Multiple Myeloma Research and Treatments
- Immunology top 10%
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
-
- Cyclization and Aryne Chemistry 9
- Synthesis and pharmacology of benzodiazepine derivatives 6
- Synthesis and Reactivity of Heterocycles 3
- Oncology 10
- Peptidase Inhibition and Analysis 3
- Co-authors
- David T. Scadden (3 shared papers)Peter Lopez (1 shared paper)James D. Levine (1 shared paper)Anna C. Berardi (1 shared paper)Chafen Lu (4 shared papers)Marion Dorsch (4 shared papers)Yajun Xu (4 shared papers)Timothy D. Ocain (3 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (3 papers)Tetrahedron (3 papers)Cancer Research (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Journal of the Chemical Society Perkin Transactions 1 (2 papers)
- Partner nations
- United StatesFranceChina
In The Last Decade
Anlai Wang
38 papers receiving 900 citations
Peers
Comparison fields: 5 of 96
- Hematology 297
- Immunology 345
- Genetics 93
- Oncology 210
- Physiology 25
Countries citing papers authored by Anlai Wang
This map shows the geographic impact of Anlai Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anlai Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anlai Wang more than expected).
Fields of papers citing papers by Anlai Wang
This network shows the impact of papers produced by Anlai Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anlai Wang. The network helps show where Anlai Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Anlai Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 346 | |
| 2 | 2020 | 87 | |
| 3 | 2005 | 63 | |
| 4 | 2006 | 62 | |
| 5 | 1997 | 59 | |
| 6 | 2006 | 54 | |
| 7 | 2000 | 34 | |
| 8 | 2005 | 31 | |
| 9 | 2014 | 24 | |
| 10 | 2009 | 21 | |
| 11 | 2000 | 17 | |
| 12 | 2021 | 12 | |
| 13 | 1994 | 11 | |
| 14 | 2022 | 10 | |
| 15 | 1999 | 9 | |
| 16 | 2018 | 8 | |
| 17 | 1998 | 8 | |
| 18 | 2020 | 7 | |
| 19 | 1998 | 7 | |
| 20 | 2000 | 6 |
About Anlai Wang
Anlai Wang is a scholar working on Organic Chemistry, Oncology, Immunology, Molecular Biology and Pathology and Forensic Medicine, having authored 39 papers that have together received 928 indexed citations. Recurring topics across this work include Cyclization and Aryne Chemistry (9 papers), Immune Cell Function and Interaction (7 papers), Synthesis and pharmacology of benzodiazepine derivatives (6 papers), Cancer Mechanisms and Therapy (5 papers), Chemical Reactions and Mechanisms (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Synthesis and Reactivity of Heterocycles (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Hematology (297 citations), Immunology (345 citations), Genetics (93 citations), Oncology (210 citations) and Physiology (25 citations). Anlai Wang has collaborated with scholars based in United States, France and China. Frequent co-authors include David T. Scadden, Peter Lopez, James D. Levine, Anna C. Berardi, Chafen Lu, Marion Dorsch, Yajun Xu, Timothy D. Ocain, Shijie Lu and Bruce Jaffee. Their work appears in journals such as Biochemical and Biophysical Research Communications, Tetrahedron, Cancer Research, Bioorganic & Medicinal Chemistry Letters and Journal of the Chemical Society Perkin Transactions 1.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.